These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8731386)

  • 21. Atorvastatin Pretreatment Attenuates Ischemic Brain Edema by Suppressing Aquaporin 4.
    Cheng ZJ; Dai TM; Shen YY; He JL; Li J; Tu JL
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3247-3255. PubMed ID: 30093197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.
    Kitagawa H; Hayashi T; Mitsumoto Y; Koga N; Itoyama Y; Abe K
    Stroke; 1998 Jul; 29(7):1417-22. PubMed ID: 9660398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
    Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
    Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.
    Zausinger S; Lumenta DB; Pruneau D; Schmid-Elsaesser R; Plesnila N; Baethmann A
    Brain Res; 2002 Sep; 950(1-2):268-78. PubMed ID: 12231253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
    Lo EH; Pierce AR; Mandeville JB; Rosen BR
    Stroke; 1997 Feb; 28(2):439-46; discussion 446-7. PubMed ID: 9040703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro.
    Nelson RM; Hainsworth AH; Lambert DG; Jones JA; Murray TK; Richards DA; Gabrielsson J; Cross AJ; Green AR
    Neuropharmacology; 2001 Aug; 41(2):159-66. PubMed ID: 11489452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain.
    Zhao Y; Patzer A; Gohlke P; Herdegen T; Culman J
    Eur J Neurosci; 2005 Jul; 22(1):278-82. PubMed ID: 16029218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nimodipine attenuates both ischaemia-induced brain oedema and mortality in a rat novel transient middle cerebral artery occlusion model.
    Hara H; Nagasawa H; Kogure K
    Acta Neurochir Suppl (Wien); 1990; 51():251-3. PubMed ID: 2089908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats.
    Yang GY; Chen SF; Kinouchi H; Chan PH; Weinstein PR
    Stroke; 1992 Sep; 23(9):1331-6. PubMed ID: 1325690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia.
    Kusumoto K; Mackay KB; McCulloch J
    Brain Res; 1992 Mar; 576(1):147-51. PubMed ID: 1325235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective Effect of VEGF-Mimetic Peptide QK in Experimental Brain Ischemia Induced in Rat by Middle Cerebral Artery Occlusion.
    Pignataro G; Ziaco B; Tortiglione A; Gala R; Cuomo O; Vinciguerra A; Lapi D; Mastantuono T; Anzilotti S; D'Andrea LD; Pedone C; di Renzo G; Annunziato L; Cataldi M
    ACS Chem Neurosci; 2015 Sep; 6(9):1517-25. PubMed ID: 26173041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of systemic hypothermia and selective brain cooling on ischemic brain damage and swelling.
    Park CK; Jun SS; Kim MC; Kang JK
    Acta Neurochir Suppl; 1998; 71():225-8. PubMed ID: 9779191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of clomethiazole in a model of global ischemia.
    Chaulk D; Wells J; Evans S; Jackson D; Corbett D
    Exp Neurol; 2003 Aug; 182(2):476-82. PubMed ID: 12895459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier permeability to micromolecules and edema formation in the early phase of incomplete continuous ischemia.
    Sampaolo S; Nakagawa Y; Iannotti F; Cervos-Navarro J; Bonavita V
    Acta Neuropathol; 1991; 82(2):107-11. PubMed ID: 1927266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology.
    Gill R; Sibson NR; Hatfield RH; Burdett NG; Carpenter TA; Hall LD; Pickard JD
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):1-11. PubMed ID: 7798326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome.
    Nisijima K; Shioda K; Yoshino T; Takano K; Kato S
    Neurochem Int; 2003 Jul; 43(2):155-64. PubMed ID: 12620284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole.
    Green AR; De Souza RJ; Williams JL; Murray TK; Cross AJ
    Neuropharmacology; 1992 Apr; 31(4):315-21. PubMed ID: 1381816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.